CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a single arm, Phase II study using the combination of atezolizumab and bevicacizumab in women with advanced, recurrent or persistent endometrial...
Phase 2
Saint Louis, Missouri, United States and 2 other locations
This is a Phase IB/II multi-cohort study designed to evaluate the efficacy and safety of targeted agents with or without cancer immune check ...
Phase 1, Phase 2
St Louis, Missouri, United States and 20 other locations
This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...
Phase 2
Saint Louis, Missouri, United States and 65 other locations
Patients with inoperable endometrial cancer have limited treatment options. PD-L1 expression is common in endometrial cancers...
Phase 1
Saint Louis, Missouri, United States
DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...
Phase 3
Saint Louis, Missouri, United States and 237 other locations
Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...
Phase 3
St Louis, Missouri, United States and 243 other locations
This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have ...
Phase 2, Phase 3
Saint Louis, Missouri, United States and 82 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
St Louis, Missouri, United States and 168 other locations
drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...
Phase 1
Saint Louis, Missouri, United States and 73 other locations
with paclitaxel in patients with recurrent high-grade uterine cancer. Other objectives include overall safety and tolerability as well as ra...
Phase 1
St Louis, Missouri, United States and 3 other locations
Clinical trials
Research sites
Resources
Legal